Earnings dates and session timing shown here are aggregated from third-party sources, are frequently estimated, and are subject to change or confirmation by the reporting company. Nothing on this site is financial advice.
Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.
Quotes and fundamental data are delayed and provided for informational purposes only — nothing on this page is financial advice. Figures are as reported by the company and its data providers and may be revised. Estimates reflect analyst consensus at the time of each report.
$269.12
| Quarter | EPS | Revenue | Price move | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Est | Adj | Result | GAAP | Est | Actual | Surprise | 1D Pre | On-Day | 1D Post | |
Q ended Jun 30, 2026 Reported Jul 15, 2026 | $2.84 | $2.90 | Beat +2.1% | $2.27 | $25.1B | $25.3B | +0.8% | 1D Pre-1.5% | On-Day-2.7% | 1D Post+1.2% |
Q ended Mar 31, 2026 Reported Apr 14, 2026 | $2.68 | $2.70 | Beat +0.7% | — | $23.6B | $24.1B | +2.1% | 1D Pre-0.2% | On-Day+0.9% | 1D Post-0.6% |
Q ended Dec 31, 2025 Reported Jan 21, 2026 | $2.46 | $2.46 | ||||||||
Dashed outlines show the analyst consensus estimate for periods where one was published. Hover or tap a bar for exact figures. Values as reported; not adjusted for splits after the report date.
| Met 0.0% |
| — |
| $24.2B |
| $24.6B |
| +1.7% |
| 1D Pre-0.2% |
| On-Day-0.1% |
| 1D Post+0.2% |
Q ended Sep 30, 2025 Reported Oct 14, 2025 | $2.76 | $2.80 | Beat +1.4% | — | $23.8B | $24.0B | +0.8% | 1D Pre+0.1% | On-Day-0.0% | 1D Post+0.2% |